companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

NETRICOM INC

EDMONTON-Canada

Company Name:
Corporate Name:
NETRICOM INC
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 17019 105 Ave NW,EDMONTON,AB,Canada 
ZIP Code:
Postal Code:
T5S1M5 
Telephone Number: 7804810050 
Fax Number: 7804810090 
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
173127 
USA SIC Description:
Communications Contractors 
Number of Employees:
20 to 49 
Sales Amount:
$2.5 to 5 million 
Credit History:
Credit Report:
Excellent 
Contact Person:
Tom Hymen 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
NETTWORX
NETSTAR COMPUTER GROUP
NETSMART INC
Next company profile:
NETRICOM
NETMAR ADVERTISING DELIVERY
NETLINE 2000 INC










Company News:
  • Preparation of a solid self-microemulsifying drug delivery . . .
    S-SMEDDS were successfully prepared by HME, and an HMPCAS matrix was able to avoid microemulsion reconstitution and retain drug release in pH 1 2 (12 97%–25 54%) Conversely, microemulsion reconstitution and drug release were gradual in pH 6 8 and complete for some formulations
  • Preparation of Solid Self-Nanoemulsifying Drug Delivery . . .
    The present study focused on a new formulation approach to improving the solubility of drugs with poor aqueous solubility A hot melt extrusion (HME) process was applied to prepare drug-loaded solid self-nanoemulsifying drug delivery systems
  • A Conceptual Analysis of Solid Self-emulsifying Drug Delivery . . .
    SSMEDDS are physically stable, easy to manufacture, easy to fill in gelatin capsules as well as improve the drug bioavailability by releasing the drug in the emulsion form into the gastrointestinal tract and enable smooth absorption of the drug through the intestinal lymphatic pathway
  • HME as Advanced Approach for Development of Solid Self . . .
    The pharmaceutical industry is paying more and more attention to hot-melt extrusion (HME), but this technology’s promise for creating solid self-emulsifying drug delivery systems (S-SMEDDS) has not yet been fully realized
  • Preparation and Pharmacokinetics Evaluation of Solid Self . . .
    The results suggested that S-SMEDDS was an effective oral solid dosage form, which can improve the solubility and oral bioavailability of poorly water-soluble drug osthole KEY WORDS: osthole; self-microemulsion; spherical crystallization technique; bioavailability
  • Development of self-microemulsifying drug delivery system and . . .
    Solid-SMEDDS may be considered as a better solid dosage form as solidified formulations are more ideal than liquid ones in terms of its stability These results suggest the potential use of SMEDDS and solid-SMEDDS to improve the dissolution and hence oral bioavailability of poorly water-soluble drugs like telmisartan through oral route
  • Preparation of Solid Self-Nanoemulsifying Drug Delivery . . .
    A hot melt extrusion (HME) process was applied to prepare drug-loaded solid self-nanoemulsifying drug delivery systems (S-SNEDDS) by co-extrusion of liquid SNEDDS (L-SNEDDS) and different polymeric carriers Experiments were performed with L-SNEDDS formulations containing celecoxib, efavirenz or fenofibrate as model drugs




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer